Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
Sector: Pharmaceutical Preparations
Industry: Medical - Diagnostics & Research
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 84.07M shares outstanding
DEMainz Biomed N.V. is a specialized enterprise in the field of molecular genetics, primarily focused on cancer diagnostics.
The company's core mission involves developing and producing market-ready molecular genetic diagnostic solutions specifically engineered for life-threatening medical conditions. Beyond creation, it actively engages in the global commercialization of its product portfolio, reaching markets across Europe, the United States, and other international territories. This firm was established on March 8, 2021, and maintains its headquarters in Mainz, Germany.
Avraham Ben-Tzvi
Director
David Lazar
Chief Executive Officer and Director
David Natan
Director
Peter O’Rourke
Non-Executive Director
Employees
26
Country
DE
Sector
Healthcare
Website
mainzbiomed.com
Loading congressional disclosures…
based on 84.07M shares outstanding
DE30d Avg
413.55K
60d Avg
675.55K
90d Avg
685.86K
